Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MiMedx Group, Inc.(MDXG) | 28,195,249 | 28,195,249 | 0 | $247.27M | $217.10M | 62.97% | -$30.17M |
| Bioventus Inc.CL A(BVS) | 13,021,324 | 13,021,324 | 0 | $68.62M | $67.71M | 19.64% | -$911.5K |
| EyePoint, Inc.(EYPT) | 2,337,786 | 1,551,521 | -786,265 | $54.03M | $32.07M | 9.30% | -$21.96M |
| TELA Bio, Inc.(TELA) | 4,110,709 | 4,110,709 | 0 | $27.21M | $23.31M | 6.76% | -$3.91M |
| Revance Therapeutics Inc | 457,085 | 457,085 | 0 | $4.02M | $2.25M | 0.65% | -$1.77M |
| MediciNova, Inc.(MNOV) | 1,105,941 | 1,105,941 | 0 | $1.66M | $1.60M | 0.47% | -$55.3K |
| Venus Concept, Inc. | 0 | 1,089,190 | +1,089,190 | $0 | $752.6K | 0.22% | +$752.6K |
| Venus Concept, Inc. | 1,089,190 | 0 | -1,089,190 | $1.29M | $0 | — | -$1.29M |